Cost Effectiveness Analysis of Tyrosine Kinase Inhibitors in the Management of Chronic Myeloid Leukemia
Crossref DOI link: https://doi.org/10.30574/gscbps.2025.33.2.0430
Published Online: 2025-11-30
Update policy: https://doi.org/10.30574/gscbps.ourcrossmarkpolicy
BENBACHIR, Hamza
HABERROU, Wiam
OUSSAR, Manel
SAIAH, Kawther
ENTASULTAN, Badra
BERRICHI, Mustapha
